Skip to main navigation
Skip to content
Corcept Corcept
Main Menu
  • Contact Us
  • About
    • About Corcept
    • Board of Directors
    • Executive Team
    • Educational Grants
    • Contact Us
  • Product
    • Korlym® for Cushing's Syndrome
    • Medical Information Request
  • Patients
  • Research & Pipeline
    • Cortisol Modulation
    • Cortisol Modulation Therapeutic Platform
    • Pipeline and Clinical Trials
    • Publications
    • Investigator-Initiated Studies
    • Compassionate Use
  • Investors
    • Investors Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Careers
    • Working at Corcept
    • Benefits
    • Testimonials
    • Current Opportunities

SEC Filing Details

Home - Investor Relations - SEC Filings - 4/A

SEC Filing Details

Document Details

Form
4/A
Filing Date
Mar 18, 2022
Document Date
May 11, 2021
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Corcept
Issuer
CORCEPT THERAPEUTICS INC
Filer
MAHONEY DAVID L

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

Email Alerts
Print Page
RSS Feeds

Footer Menu

  • About
    • Executive Team
    • Board of Directors
    • Educational Grants
    • Contact Us
  • Product
    • Korlym for Cushing's Syndrome
    • Medical Information Request
    • Patients
  • Research & Pipeline
    • Cortisol Modulation
    • Cortisol Modulation Therapeutic Platform
    • Pipeline and Clinical Trials
    • Publications
    • Investigators Initiated Studies
    • Compassionate Use
  • Investors
    • Investors Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Careers
    • Benefits
    • Testimonials
    • Current Opportunities
©  2022 Corcept
  • Privacy Policy
  • Terms of Use
  • Site Map